RecruitingNot ApplicableNCT06369532

Combination of Neurostimulation and Psychotherapy to Stop Worrying

Stop Worrying, Learn to Let go Through a Combination of Neurostimulation and Psychotherapy

Sponsor

University Hospital, Ghent

Enrollment

85 participants

Start Date

Mar 6, 2024

Study Type

INTERVENTIONAL

Conditions

Sham tDCS Active tDCS

Summary

This study aims to investigate whether the combination of transcranial Direct Current Stimulation (tDCS) and cognitive-behavioral therapy (CBT) is more effective for treating repetitive negative thinking (RNT) in patients with the symptom of high rumination. High ruminators will be included (Group1, active tDCS-CBT group; Group2, sham tDCS-CBT group). All patients will receive active or sham tDCS.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active tDCS and a medical device called Sham tDCS for people with active tdcs and sham tdcs. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive tDCS

During the whole therapy period, active tDCS group will receive active tDCS after CBT. They also receive active home-based tDCS.

DEVICESham tDCS

The sham tDCS group will receive sham tDCS after CBT. They also receive sham home-based tDCS.

Locations(1)

University Hospital Ghent

Ghent, East-Flanders, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06369532

Related Trials

tdCS Combined With Treadmill Training in Patients With Multiple Sclerosis

NCT069862782 locations